Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001060931 | SCV001225651 | pathogenic | Anemia, nonspherocytic hemolytic, due to G6PD deficiency | 2022-07-11 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt G6PD protein function. ClinVar contains an entry for this variant (Variation ID: 10407). This variant is also known as G6PD NanKang. This missense change has been observed in individual(s) with G6PD deficiency (PMID: 16329560, 20582980, 30045279). This variant is present in population databases (rs137852343, gnomAD 0.02%). This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 173 of the G6PD protein (p.Phe173Leu). |
Dunham Lab, |
RCV001060931 | SCV002599333 | pathogenic | Anemia, nonspherocytic hemolytic, due to G6PD deficiency | 2022-08-12 | criteria provided, single submitter | curation | Variant found in unrelated hemizygotes with deficiency, some with jaundice (PS4_M, PP4). Decreased activity in red blood cells (5-33%) (PS3). Below expected carrier frequency in gnomAD (PM2). Reported as pathogenic by Invitae (PP5). Post_P 0.994 (odds of pathogenicity 1517, Prior_P 0.1). |
Baylor Genetics | RCV003460458 | SCV004195399 | pathogenic | Malaria, susceptibility to | 2023-07-26 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000011150 | SCV000031377 | other | G6PD NANKANG | 2013-04-18 | no assertion criteria provided | literature only |